The effect of smoking on intestinal inflammation: What can be learned from animal models?

Journal of Crohn's and Colitis

Volumn 6, Issue 1, 2012, Pages 1-12

  Verschuere, Stephanie ^a   De Smet, Rebecca ^a   Allais, Liesbeth ^a   Cuvelier, Claude A ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Animal model; Cigarette smoke; Inflammation associated neoplasia; Inflammatory bowel disease; Nicotine; Oxidative stress

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; CARBON MONOXIDE; CIGARETTE SMOKE; HAPTEN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTESTINAL TREFOIL FACTOR; IODOACETAMIDE; MYELOPEROXIDASE; NICOTINE; OXAZOLONE; PROSTAGLANDIN E2; SUPEROXIDE DISMUTASE; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA; XANTHINE OXIDASE;

ANIMAL MODEL; APOPTOSIS; ATTENUATION; CARCINOGENESIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CIGARETTE SMOKING; COLITIS; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE ACTIVITY; DNA DAMAGE; ENTEROCOLITIS; INTESTINE EPITHELIUM; LIPID PEROXIDATION; LUNG BURN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL NEOPLASMS; INTESTINES; MODELS, ANIMAL; NICOTINE; OXIDATIVE STRESS; RISK FACTORS; SMOKING; TOBACCO;

EID: 84855961122     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2011.09.006     Document Type: Review

References (60)

1. Harries A.D., Baird A., Rhodes J. Non-smoking: a feature of ulcerative colitis. Br Med J (Clin Res Ed) 1982, 284:706.
2. Benoni C., Nilsson A. Smoking habits in patients with inflammatory bowel disease. Scand J Gastroenterol 1984, 19:824-830.
3. Bernstein C.N. New insights into IBD epidemiology: are there any lessons for treatment?. Dig Dis 2010, 28:406-410.
4. Carbonnel F., Jantchou P., Monnet E., Cosnes J. Environmental risk factors in Crohn's disease and ulcerative colitis: an update. Gastroenterol Clin Biol 2009, 33(Suppl. 3):S145-S157.
5. Reif S., Lavy A., Keter D., Fich A., Eliakim R., Halak A., et al. Lack of association between smoking and Crohn's disease but the usual association with ulcerative colitis in Jewish patients in Israel: a multicenter study. Am J Gastroenterol 2000, 95:474-478.
6. Reif S., Klein I., Arber N., Gilat T. Lack of association between smoking and inflammatory bowel disease in Jewish patients in Israel. Gastroenterology 1995, 108:1683-1687.
7. Jones D.T., Osterman M.T., Bewtra M., Lewis J.D. Passive smoking and inflammatory bowel disease: a meta-analysis. Am J Gastroenterol 2008, 103:2382-2393.
8. Karban A., Eliakim R. Effect of smoking on inflammatory bowel disease: is it disease or organ specific?. World J Gastroenterol 2007, 13:2150-2152.
9. Birrenbach T., Bocker U. Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications. Inflamm Bowel Dis 2004, 10:848-859.
10. Mehta H., Nazzal K., Sadikot R.T. Cigarette smoking and innate immunity. Inflamm Res 2008, 57:497-503.
11. Phipps A.I., Baron J., Newcomb P.A. Prediagnostic smoking history, alcohol consumption, and colorectal cancer survival: the Seattle Colon Cancer Family Registry. Cancer Apr 14 2011, published online. (Epub ahead of print). 10.1002/cncr.26114.
12. Ng S.C., Woodrow S., Patel N., Subhani J., Harbord M. Role of genetic and environmental factors in British twins with inflammatory bowel disease. Inflamm Bowel Dis May 6 2011, published online. (Epub ahead of print). 10.1002/ibd.21747.
13. Eliakim R., Fan Q.X., Babyatsky M.W. Chronic nicotine administration differentially alters jejunal and colonic inflammation in interleukin-10 deficient mice. Eur J Gastroenterol Hepatol 2002, 14:607-614.
14. Eliakim R., Karmeli F., Cohen P., Heyman S.N., Rachmilewitz D. Dual effect of chronic nicotine administration: augmentation of jejunitis and amelioration of colitis induced by iodoacetamide in rats. Int J Colorectal Dis 2001, 16:14-21.
15. Eliakim R., Karmeli F., Rachmilewitz D., Cohen P., Fich A. Effect of chronic nicotine administration on trinitrobenzene sulphonic acid-induced colitis. Eur J Gastroenterol Hepatol 1998, 10:1013-1019.
16. Sykes A.P., Brampton C., Klee S., Chander C.L., Whelan C., Parsons M.E. An investigation into the effect and mechanisms of action of nicotine in inflammatory bowel disease. Inflamm Res 2000, 49:311-319.
17. Ghia J.E., Blennerhassett P., Kumar-Ondiveeran H., Verdu E.F., Collins S.M. The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology 2006, 131:1122-1130.
18. Thomas G.A., Pullan R.D., Zijlstra F.J., Rankin B.J., Russell M.A., Feyerabend C., et al. Effect of nicotine on large bowel mucus thickness, eicosanoids and faecal proteinase in ferrets. Eur J Gastroenterol Hepatol 1997, 9:179-182.
19. Zijlstra F.J., Srivastava E.D., Rhodes M., van Dijk A.P., Fogg F., Samson H.J., et al. Effect of nicotine on rectal mucus and mucosal eicosanoids. Gut 1994, 35:247-251.
20. Van Dijk J.P., Madretsma G.S., Keuskamp Z.J., Zijlstra F.J. Nicotine inhibits cytokine synthesis by mouse colonic mucosa. Eur J Pharmacol 1995, 278:R11-R12.
21. Galitovskiy V., Qian J., Chernyavsky A.I., Marchenko S., Gindi V., Edwards R.A., et al. Cytokine-induced alterations of {alpha}7 nicotinic receptor in colonic CD4 T cells mediate dichotomous response to nicotine in murine models of Th1/Th17- versus Th2-mediated colitis. J Immunol 2011, 187:2677-2687.
22. Snoek S.A., Verstege M.I., van der Zanden E.P., Deeks N., Bulmer D.C., Skynner M., et al. Selective alpha7 nicotinic acetylcholine receptor agonists worsen disease in experimental colitis. Br J Pharmacol 2010, 160:322-333.
23. Hegazi R.A., Rao K.N., Mayle A., Sepulveda A.R., Otterbein L.E., Plevy S.E. Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway. J Exp Med 2005, 202:1703-1713.
24. Sheikh S.Z., Hegazi R.A., Kobayashi T., Onyiah J.C., Russo S.M., Matsuoka K., et al. An anti-inflammatory role for carbon monoxide and heme oxygenase-1 in chronic Th2-mediated murine colitis. J Immunol 2011, 186:5506-5513.
25. Takagi T., Naito Y., Mizushima K., Akagiri S., Suzuki T., Hirata I., et al. Inhalation of carbon monoxide ameliorates TNBS-induced colitis in mice through the inhibition of TNF-alpha expression. Dig Dis Sci 2010, 55:2797-2804.
26. Ko J.K., Cho C.H. The diverse actions of nicotine and different extracted fractions from tobacco smoke against hapten-induced colitis in rats. Toxicol Sci 2005, 87:285-295.
27. Takamura T., Harama D., Matsuoka S., Shimokawa N., Nakamura Y., Okumura K., et al. Activation of the aryl hydrocarbon receptor pathway may ameliorate dextran sodium sulfate-induced colitis in mice. Immunol Cell Biol 2010, 88:685-689.
28. Benson J.M., Shepherd D.M. Aryl hydrocarbon receptor activation by TCDD reduces inflammation associated with Crohn's disease. Toxicol Sci 2011, 120:68-78.
29. Galeazzi F., Blennerhassett P.A., Qiu B., O'Byrne P.M., Collins S.M. Cigarette smoke aggravates experimental colitis in rats. Gastroenterology 1999, 117:877-883.
30. Chow J.Y., Ma L., Cho C.H. An experimental model for studying passive cigarette smoking effects on gastric ulceration. Life Sci 1996, 58:2415-2422.
31. Guo X., Ko J.K., Mei Q.B., Cho C.H. Aggravating effect of cigarette smoke exposure on experimental colitis is associated with leukotriene B(4) and reactive oxygen metabolites. Digestion 2001, 63:180-187.
32. Guo X., Wang W.P., Ko J.K., Cho C.H. Involvement of neutrophils and free radicals in the potentiating effects of passive cigarette smoking on inflammatory bowel disease in rats. Gastroenterology 1999, 117:884-892.
33. Guo X., Liu E.S., Ko J.K., Wong B.C., Ye Y., Lam S., et al. Protective role of cyclooxygenase inhibitors in the adverse action of passive cigarette smoking on the initiation of experimental colitis in rats. Eur J Pharmacol 2001, 411:193-203.
34. Sun Y.P., Wang H.H., He Q., Cho C.H. Effect of passive cigarette smoking on colonic alpha7-nicotinic acetylcholine receptors in TNBS-induced colitis in rats. Digestion 2007, 76:181-187.
35. Ko J.K., Sham N.F., Guo X., Cho C.H. Beneficial intervention of experimental colitis by passive cigarette smoking through the modulation of cytokines in rats. J Investig Med 2001, 49:21-29.
36. Liu E.S., Ye Y.N., Shin V.Y., Yuen S.T., Leung S.Y., Wong B.C., et al. Cigarette smoke exposure increases ulcerative colitis-associated colonic adenoma formation in mice. Carcinogenesis 2003, 24:1407-1413.
37. Liu E.S., Ye Y.N., Shin V.Y., Wu W.K., Wong B.C., Cho C.H. Interaction of cigarette smoking with cyclooxygenase-2 on ulcerative colitis-associated neoplasia in mice. Cancer Invest 2007, 25:750-757.
38. D'hulst A.I., Vermaelen K.Y., Brusselle G.G., Joos G.F., Pauwels R.A. Time course of cigarette smoke-induced pulmonary inflammation in mice. Eur Respir J 2005, 26:204-213.
39. Verschuere S., Bracke K.R., Demoor T., Plantinga M., Verbrugghe P., Ferdinande L., et al. Cigarette smoking alters epithelial apoptosis and immune composition in murine GALT. Lab Invest 2011, 91:1056-1067.
40. Eliakim R., Karmeli F. Divergent effects of nicotine administration on cytokine levels in rat small bowel mucosa, colonic mucosa, and blood. Isr Med Assoc J 2003, 5:178-180.
41. Martey C.A., Baglole C.J., Gasiewicz T.A., Sime P.J., Phipps R.P. The aryl hydrocarbon receptor is a regulator of cigarette smoke induction of the cyclooxygenase and prostaglandin pathways in human lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 2005, 289:L391-L399.
42. Lawrence B.P., Kerkvliet N.I. Role of altered arachidonic acid metabolism in 2,3,7, 8-tetrachlorodibenzo-p-dioxin-induced immune suppression in C57Bl/6 mice. Toxicol Sci 1998, 42:13-22.
43. Rickert R.R., Carter H.W. The "early" ulcerative lesion of Crohn's disease: correlative light- and scanning electron-microscopic studies. J Clin Gastroenterol 1980, 2:11-19.
44. Fujimura Y., Kamoi R., Iida M. Pathogenesis of aphthoid ulcers in Crohn's disease: correlative findings by magnifying colonoscopy, electron microscopy, and immunohistochemistry. Gut 1996, 38:724-732.
45. Faux S.P., Tai T., Thorne D., Xu Y., Breheny D., Gaca M. The role of oxidative stress in the biological responses of lung epithelial cells to cigarette smoke. Biomarkers 2009, 14(Suppl. 1):90-96.
46. Wang H., Yu M., Ochani M., Amella C.A., Tanovic M., Susarla S., et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003, 421:384-388.
47. Ingram J.R., Rhodes J., Evans B.K., Thomas G.A. Nicotine enemas for active Crohn's colitis: an open pilot study. Gastroenterol Res Pract 2008, 2008:237185.
48. Cosnes J., Nion-Larmurier I., Afchain P., Beaugerie L., Gendre J.P. Gender differences in the response of colitis to smoking. Clin Gastroenterol Hepatol 2004, 2:41-48.
49. Cosnes J. Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. Best Pract Res Clin Gastroenterol 2004, 18:481-496.
50. Ekbom A., Helmick C., Zack M., Adami H.O. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990, 323:1228-1233.
51. Ullman T.A., Itzkowitz S.H. Intestinal inflammation and cancer. Gastroenterology 2011, 140:1807-1816.
52. Velayos F.S., Loftus E.V., Jess T., Harmsen W.S., Bida J., Zinsmeister A.R., et al. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: a case-control study. Gastroenterology 2006, 130:1941-1949.
53. Pohl C., Hombach A., Kruis W. Chronic inflammatory bowel disease and cancer. Hepatogastroenterology 2000, 47:57-70.
54. Nikfar S., Ehteshami-Ashar S., Rahimi R., Abdollahi M. Systematic review and meta-analysis of the efficacy and tolerability of nicotine preparations in active ulcerative colitis. Clin Ther 2010, 32:2304-2315.
55. McGrath J., McDonald J.W., Macdonald J.K. Transdermal nicotine for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2004, CD004722.
56. Borovikova L.V., Ivanova S., Zhang M., Yang H., Botchkina G.I., Watkins L.R., et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000, 405:458-462.
57. Tracey K.J. Understanding immunity requires more than immunology. Nat Immunol 2010, 11:561-564.
58. Monteleone I., Rizzo A., Sarra M., Sica G., Sileri P., Biancone L., et al. Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract. Gastroenterology 2011, 141:237-248.
59. McGilligan V.E., Wallace J.M., Heavey P.M., Ridley D.L., Rowland I.R. Hypothesis about mechanisms through which nicotine might exert its effect on the interdependence of inflammation and gut barrier function in ulcerative colitis. Inflamm Bowel Dis 2007, 13:108-115.
60. Targan S.R., Karp L.C. Defects in mucosal immunity leading to ulcerative colitis. Immunol Rev 2005, 206:296-305.